64 related articles for article (PubMed ID: 1893465)
41. Monocyte function in Hodgkin's disease.
Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
[TBL] [Abstract][Full Text] [Related]
42. Disseminated varicella infection: treatment with transfer factor in a patient with Hodgkin's disease.
Ng RP
Scand J Infect Dis; 1977; 9(2):139-40. PubMed ID: 331459
[TBL] [Abstract][Full Text] [Related]
43. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
[TBL] [Abstract][Full Text] [Related]
44. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
[TBL] [Abstract][Full Text] [Related]
45. [Blastic transformation of lymphocytes stimulated with phytohemaglutinins as a criterion of evaluation of the clinical state of patients and efficiency of treatment in Hodgkin's disease].
Pluzańska A
Pol Arch Med Wewn; 1969 Dec; 43(6):1563-70. PubMed ID: 4905199
[No Abstract] [Full Text] [Related]
46. Letter: Transfer factor in Hodgkin's disease.
Thornes RD; Braeman J; Bell JN; Browne O
Lancet; 1975 Nov; 2(7944):1101. PubMed ID: 53595
[No Abstract] [Full Text] [Related]
47. The study of human transfer factor.
Li ZL
Sci Sin B; 1985 Apr; 28(4):394-401. PubMed ID: 4012263
[TBL] [Abstract][Full Text] [Related]
48. Use of transfer factor in immunosuppressed surgical patients.
Garritano CRO; Nubila FD; Couto RM; Fiorelli RKA; Aun LB
Rev Col Bras Cir; 2017; 44(5):452-456. PubMed ID: 29019573
[TBL] [Abstract][Full Text] [Related]
49. [The dialysate of leukocyte homogenate in the treatment of sepsis].
Lokaj J
Bratisl Lek Listy; 1988 Aug; 89(8):586-90. PubMed ID: 3179765
[No Abstract] [Full Text] [Related]
50. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
51. [Treatment of Hodgkin's malignant lymphoma in children and adolescents by immunomodulation with a dialysate of human leukocytes].
Mydlil J
Cesk Pediatr; 1991 May; 46(5):266-9. PubMed ID: 1893465
[TBL] [Abstract][Full Text] [Related]
52. Aspecific transfer factor in children with Hodgkin's disease.
Pasino M; Vadalà CR; Tonini GP; Comelli A; Perutelli P
Boll Ist Sieroter Milan; 1976; 55(2):168-73. PubMed ID: 1088071
[TBL] [Abstract][Full Text] [Related]
53. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
54. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease.
Lukács K; Kávai M; Berényi E; Frendl G; Schröder I; Szegedi G
Haematologia (Budap); 1985; 18(2):105-13. PubMed ID: 3161810
[TBL] [Abstract][Full Text] [Related]
55. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
Khan A; Thometz D; Garrison O; Hill JM
Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
